Press releases

Press Releases

Three new Board members join IFFIm as it marks 20 years

01 Oct 2026

Philip Brown, Alex Friedman and Sungsup Ra join the IFFIm Board, bringing experience from across capital markets, investment, impact measurement and development finance as the organisation considers what its proven financing model needs for the years ahead.

IFFIm returns to market with US$1 billion 5-year bond to support global vaccine programs

22 Apr 2026

Funds to support Gavi immunisation programmes. This bond marks 20 years since IFFIm’s inaugural issuance.

Georgina Baker appointed Chair of the International Finance Facility for Immunisation Board

22 Oct 2025

London, 22 October 2025 – The International Finance Facility for Immunisation (IFFIm) today announced the appointment of Georgina Baker as Chair of its Board of Directors, effective 1 January 2026. Ms Baker succeeds Ken Lay, who has led the Board since 2021 and will continue to serve as a Director through 2026 to ensure a smooth transition and cont...

IFFIm sterling bond takes total vaccine bond issuance over US$ 10 billion milestone

11 Jun 2025

The International Finance Facility for Immunisation (IFFIm) today announced the settlement of its £300 million, 3-year 4.25% fixed-rate bond that was announced on 3 June.  This is the third bond issue in pound sterling and a powerful reaffirmation of investor confidence in vaccine bonds as a tool for global health impact. With this latest...

IFFIm returns to market with £300 million 3-year bond to support global vaccine programs

03 Jun 2025

Proceeds will fund Gavi’s immunisation initiatives, including HPV and malaria.

IFFIm increases its most recent bond by US$ 250 million to total US$ 1.25 billion

23 Apr 2025

This week, the International Finance Facility for Immunisation (IFFIm) increased by US$ 250 million the October 2024 bond, which had previously raised US$1 billion.

IFFIm returns to market with US$ 1 billion 3-year bond to support global vaccine programs*

23 Oct 2024

Funds will support Gavi’s immunisation initiatives and CEPI’s vaccine research.